166 related articles for article (PubMed ID: 36639698)
1. Differential diagnosis of uterine adenosarcoma: identification of JAZF1-BCORL1 rearrangement by comprehensive cancer genomic profiling.
Hasegawa C; Washimi K; Hiroshima Y; Kasajima R; Kikuchi K; Notomi T; Kato H; Hiruma T; Sato S; Okubo Y; Yoshioka E; Ono K; Miyagi Y; Yokose T
Diagn Pathol; 2023 Jan; 18(1):5. PubMed ID: 36639698
[TBL] [Abstract][Full Text] [Related]
2. BCOR Expression in Mullerian Adenosarcoma: A Potential Diagnostic Pitfall.
Muthukumarana V; Fix DJ; Stolnicu S; Park KJ; Soslow RA; Benayed R; Ladanyi M; Antonescu CR; Chiang S
Am J Surg Pathol; 2020 Jun; 44(6):765-770. PubMed ID: 32011345
[TBL] [Abstract][Full Text] [Related]
3. An Unusual Benign Uterine Stromal Spindle Cell Tumor Harboring JAZF1::BCORL1.
Rodriguez Pena MDC; Mubeen A; Harada S; Prieto Granada CN
Int J Gynecol Pathol; 2023 May; 42(3):319-324. PubMed ID: 35838627
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and genomic characterization of BCORL1-driven high-grade endometrial stromal sarcomas.
Lin DI; Huang RSP; Mata DA; Decker B; Danziger N; Lechpammer M; Hiemenz M; Ramkissoon SH; Ross JS; Elvin JA
Mod Pathol; 2021 Dec; 34(12):2200-2210. PubMed ID: 34302054
[TBL] [Abstract][Full Text] [Related]
5. NTRK fusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including adenosarcoma.
Rabban JT; Devine WP; Sangoi AR; Poder L; Alvarez E; Davis JL; Rudzinski E; Garg K; Bean GR
Histopathology; 2020 Jul; 77(1):100-111. PubMed ID: 31971278
[TBL] [Abstract][Full Text] [Related]
6. Primary extra-uterine and extra-ovarian mullerian adenosarcoma: case report and literature review.
Mandato VD; Torricelli F; Mastrofilippo V; Valli R; Aguzzoli L; La Sala GB
BMC Cancer; 2018 Feb; 18(1):134. PubMed ID: 29402239
[TBL] [Abstract][Full Text] [Related]
7. Metastasizing uterine mullerian adenosarcoma in a young female: Diagnostic enigma.
Patnayak R; Rukmangadha N; Architha P; Reddy GS; Lakshmi AY; Kannan T; Jena A
Indian J Pathol Microbiol; 2018; 61(3):440-442. PubMed ID: 30004077
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical markers and the clinical course of adenosarcoma: a series of seven cases.
Omi M; Tonooka A; Chiba T; Tanaka Y; Fusegi A; Aoki Y; Nomura H; Kanao H; Takazawa Y
Diagn Pathol; 2020 Sep; 15(1):119. PubMed ID: 32972432
[TBL] [Abstract][Full Text] [Related]
9. Mullerian adenosarcoma of the female genital tract.
McCluggage WG
Adv Anat Pathol; 2010 Mar; 17(2):122-9. PubMed ID: 20179434
[TBL] [Abstract][Full Text] [Related]
10. An Unusual Endometrial Stromal Neoplasm With JAZF1-BCORL1 Rearrangement.
Moghaddam PA; Young RH; Ismiil ND; Bennett JA; Oliva E
Int J Gynecol Pathol; 2024 Jan; 43(1):33-40. PubMed ID: 36811828
[TBL] [Abstract][Full Text] [Related]
11. Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas.
Cotzia P; Benayed R; Mullaney K; Oliva E; Felix A; Ferreira J; Soslow RA; Antonescu CR; Ladanyi M; Chiang S
Am J Surg Pathol; 2019 May; 43(5):662-669. PubMed ID: 30789359
[TBL] [Abstract][Full Text] [Related]
12. High-grade Müllerian Adenosarcoma: Genomic and Clinicopathologic Characterization of a Distinct Neoplasm With Prevalent TP53 Pathway Alterations and Aggressive Behavior.
Hodgson A; Amemiya Y; Seth A; Djordjevic B; Parra-Herran C
Am J Surg Pathol; 2017 Nov; 41(11):1513-1522. PubMed ID: 28834809
[TBL] [Abstract][Full Text] [Related]
13. Uterine adenosarcoma detected by conventional papanicolaou smear: A case report with emphasis on integrating the immunocytochemical staining.
Lai CR; Hsu CY; Li AF
Diagn Cytopathol; 2012 Oct; 40(10):920-4. PubMed ID: 21433006
[TBL] [Abstract][Full Text] [Related]
14. JAZF1, YWHAE and BCOR gene translocation in primary extrauterine low-grade and high-grade endometrial stromal sarcomas.
Sun L; Zhao W; Zhao Z; Zhu Y
Histopathology; 2022 Apr; 80(5):809-819. PubMed ID: 34843125
[TBL] [Abstract][Full Text] [Related]
15. [Adenosarcoma of the uterus: a case report].
Fatnassi R; Amri F
J Gynecol Obstet Biol Reprod (Paris); 2005 May; 34(3 Pt 1):270-2. PubMed ID: 16012388
[TBL] [Abstract][Full Text] [Related]
16. Uterine Adenosarcoma.
Pinto A; Howitt B
Arch Pathol Lab Med; 2016 Mar; 140(3):286-90. PubMed ID: 26927725
[TBL] [Abstract][Full Text] [Related]
17. Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss.
Lin DI; Hemmerich A; Edgerly C; Duncan D; Severson EA; Huang RSP; Ramkissoon SH; Connor YD; Shea M; Hecht JL; Ali SM; Vergilio JA; Ross JS; Elvin JA
Gynecol Oncol; 2020 May; 157(2):357-366. PubMed ID: 32156473
[TBL] [Abstract][Full Text] [Related]
18. Uterine Adenosarcoma: a Review.
Nathenson MJ; Ravi V; Fleming N; Wang WL; Conley A
Curr Oncol Rep; 2016 Nov; 18(11):68. PubMed ID: 27718181
[TBL] [Abstract][Full Text] [Related]
19. [Sarcomas and mixed mesodermal tumors of the uterus].
Günthert AR
Ther Umsch; 2011 Oct; 68(10):559-64. PubMed ID: 21968895
[TBL] [Abstract][Full Text] [Related]
20. Uterine adenosarcomas: diagnostic use of the proliferation marker Ki-67 as an adjunct to morphologic diagnosis.
Aggarwal N; Bhargava R; Elishaev E
Int J Gynecol Pathol; 2012 Sep; 31(5):447-52. PubMed ID: 22833085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
